Bruker Analyst Ratings
Bruker Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/17/2023 | 3.78% | JP Morgan | $70 → $65 | Maintains | Neutral |
05/05/2023 | 51.68% | Citigroup | $90 → $95 | Maintains | Buy |
04/19/2023 | 11.77% | Goldman Sachs | $63 → $70 | Maintains | Sell |
04/18/2023 | 11.77% | Goldman Sachs | $63 → $70 | Maintains | Sell |
02/10/2023 | 43.7% | Citigroup | $80 → $90 | Maintains | Buy |
10/21/2022 | 11.77% | UBS | → $70 | Initiates Coverage On | → Buy |
08/22/2022 | 27.73% | Citigroup | $70 → $80 | Upgrades | Neutral → Buy |
05/05/2022 | 38.91% | SVB Leerink | $85 → $87 | Maintains | Outperform |
04/13/2022 | -4.2% | Goldman Sachs | $73 → $60 | Maintains | Sell |
02/14/2022 | 35.72% | SVB Leerink | $84 → $85 | Maintains | Outperform |
11/02/2021 | 43.7% | Wells Fargo | $85 → $90 | Maintains | Equal-Weight |
09/09/2021 | 59.67% | SVB Leerink | $90 → $100 | Maintains | Outperform |
08/03/2021 | 35.72% | Wells Fargo | $70 → $85 | Maintains | Equal-Weight |
06/18/2021 | 35.72% | SVB Leerink | $80 → $85 | Maintains | Outperform |
06/15/2021 | — | Cleveland Research | Upgrades | Neutral → Buy | |
02/05/2021 | -12.18% | Wells Fargo | → $55 | Downgrades | Overweight → Equal-Weight |
01/27/2021 | 11.77% | SVB Leerink | $50 → $70 | Maintains | Outperform |
11/16/2020 | — | Wolfe Research | Upgrades | Underperform → Peer Perform | |
08/04/2020 | -24.96% | Citigroup | $38 → $47 | Maintains | Neutral |
08/04/2020 | -20.17% | SVB Leerink | $45 → $50 | Maintains | Outperform |
07/20/2020 | -21.76% | B of A Securities | $43 → $49 | Maintains | Buy |
05/07/2020 | -39.33% | Citigroup | $40 → $38 | Maintains | Neutral |
05/07/2020 | -32.94% | Wells Fargo | $50 → $42 | Maintains | Overweight |
04/28/2020 | -34.54% | UBS | $53 → $41 | Maintains | Neutral |
04/02/2020 | -44.12% | Stifel | $52 → $35 | Maintains | Hold |
04/01/2020 | — | Needham | Downgrades | Strong Buy → Hold | |
03/26/2020 | -23.36% | Barclays | $52 → $48 | Upgrades | Equal-Weight → Overweight |
03/20/2020 | -36.13% | Citigroup | $52 → $40 | Maintains | Neutral |
02/19/2020 | 0.59% | Needham | $62 → $63 | Maintains | Strong Buy |
01/08/2020 | -4.2% | Wells Fargo | → $60 | Initiates Coverage On | → Overweight |
01/07/2020 | -16.97% | Citigroup | → $52 | Initiates Coverage On | → Buy |
11/15/2019 | -15.38% | Stifel | → $53 | Initiates Coverage On | → Hold |
09/26/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
07/15/2019 | -23.36% | Goldman Sachs | $32 → $48 | Upgrades | Sell → Neutral |
05/03/2019 | — | SVB Leerink | Upgrades | Market Perform → Outperform | |
04/12/2019 | — | Deutsche Bank | Upgrades | → Buy | |
01/03/2019 | -37.73% | Needham | → $39 | Initiates Coverage On | → Strong Buy |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
10/17/2023 | 3.78% | 摩根大通 | $70→$65 | 维护 | 中性 |
05/05/2023 | 51.68% | 花旗集团 | $90→$95 | 维护 | 买 |
04/19/2023 | 11.77% | 高盛 | $63→$70 | 维护 | 卖 |
04/18/2023 | 11.77% | 高盛 | $63→$70 | 维护 | 卖 |
02/10/2023 | 43.7% | 花旗集团 | $80→$90 | 维护 | 买 |
2022年10月21日 | 11.77% | 瑞银集团 | →$70 | 开始承保 | →购买 |
2022/08/22 | 27.73% | 花旗集团 | $70→$80 | 升级 | 中性→购买 |
05/05/2022 | 38.91% | SVB Leerink | $85→$87 | 维护 | 跑赢大盘 |
04/13/2022 | -4.2% | 高盛 | $73→$60 | 维护 | 卖 |
02/14/2022 | 35.72% | SVB Leerink | $84→$85 | 维护 | 跑赢大盘 |
11/02/2021 | 43.7% | 富国银行 | $85→$90 | 维护 | 等重 |
09/09/2021 | 59.67% | SVB Leerink | $90→$100 | 维护 | 跑赢大盘 |
08/03/2021 | 35.72% | 富国银行 | $70→$85 | 维护 | 等重 |
06/18/2021 | 35.72% | SVB Leerink | $80→$85 | 维护 | 跑赢大盘 |
2021/06/15 | - | 克利夫兰研究公司 | 升级 | 中性→购买 | |
02/05/2021 | -12.18% | 富国银行 | →$55 | 评级下调 | 超重→等重 |
2021/01/27 | 11.77% | SVB Leerink | $50→$70 | 维护 | 跑赢大盘 |
11/16/2020 | - | 沃尔夫研究 | 升级 | 表现不佳的→对等设备 | |
08/04/2020 | -24.96% | 花旗集团 | $38→$47 | 维护 | 中性 |
08/04/2020 | -20.17% | SVB Leerink | $45→$50 | 维护 | 跑赢大盘 |
07/20/2020 | -21.76% | B of A证券 | $43→$49 | 维护 | 买 |
05/07/2020 | -39.33% | 花旗集团 | $40→$38 | 维护 | 中性 |
05/07/2020 | -32.94% | 富国银行 | $50→$42 | 维护 | 超重 |
04/28/2020 | -34.54% | 瑞银集团 | $53→$41 | 维护 | 中性 |
04/02/2020 | -44.12% | Stifel | $52→$35 | 维护 | 保持 |
04/01/2020 | - | 李约瑟 | 评级下调 | 强力买入→Hold | |
03/26/2020 | -23.36% | 巴克莱 | $52→$48 | 升级 | 等重→超重 |
03/20/2020 | -36.13% | 花旗集团 | $52→$40 | 维护 | 中性 |
02/19/2020 | 0.59% | 李约瑟 | $62→$63 | 维护 | 强势购买 |
1/08/2020 | -4.2% | 富国银行 | →$60 | 开始承保 | →超重 |
1/07/2020 | -16.97% | 花旗集团 | →$52 | 开始承保 | →购买 |
2019年11月15日 | -15.38% | Stifel | →$53 | 开始承保 | →保留 |
2019年09月26日 | - | B of A证券 | 升级 | 中性→购买 | |
2019年07月15日 | -23.36% | 高盛 | $32→$48 | 升级 | 卖出→中性 |
2019年05月03日 | - | SVB Leerink | 升级 | 市场表现优于→ | |
2019年4月12日 | - | 德意志银行 | 升级 | →购买 | |
2019年03月01日 | -37.73% | 李约瑟 | →$39 | 开始承保 | →强势购买 |
What is the target price for Bruker (BRKR)?
布鲁克(Bruker)的目标价是多少?
The latest price target for Bruker (NASDAQ: BRKR) was reported by JP Morgan on October 17, 2023. The analyst firm set a price target for $65.00 expecting BRKR to rise to within 12 months (a possible 3.78% upside). 6 analyst firms have reported ratings in the last year.
摩根大通于2023年10月17日报道了布鲁克(纳斯达克代码:BRKR)的最新目标价。这家分析公司将目标价定为65.00美元,预计BRKR将在12个月内上涨(可能上涨3.78%)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for Bruker (BRKR)?
布鲁克(BRKR)最近的分析师评级是多少?
The latest analyst rating for Bruker (NASDAQ: BRKR) was provided by JP Morgan, and Bruker maintained their neutral rating.
纳斯达克(Sequoia Capital:BRKR)的最新分析师评级由摩根大通提供,布鲁克维持中性评级。
When is the next analyst rating going to be posted or updated for Bruker (BRKR)?
布鲁克(Bruker)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公开财务报表,与布鲁克的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。布鲁克的上一次评级是在2023年10月17日提交的,所以你应该预计下一次评级将在2024年10月17日左右的某个时候公布。
Is the Analyst Rating Bruker (BRKR) correct?
分析师对布鲁克(BRKR)的评级正确吗?
While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $70.00 to $65.00. The current price Bruker (BRKR) is trading at is $62.63, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的布鲁克(BRKR)评级维持不变,目标价在70.00美元至65.00美元之间。布鲁克目前的交易价格为62.63美元,超出了分析师的预测区间。